ROS1+ Cancer

An Introduction to the ROS1+ Biomarker and Targeted Treatment

At first, everything felt overwhelming. But once I understood what was driving my cancer, things started to feel a little less scary.
Janet Freeman-Daily – ROS1+ Patient Advocate

Being told you have ROS1-positive lung cancer can feel like being dropped into a whole new language. In this video series, created in collaboration with TheROS1ders.org, ROS1+ patient advocates break down what ROS1+ is in plain terms, then discuss treatment options, treatment resistance and how to advocate for yourself or a loved one.

Spotlight: What is ROS1+ Cancer?

In this short video, ROS1der Lisa Goldman (diagnosed in 2014) has a conversation with ROS1 expert Dr. Ross Camidge, where he explains what exactly ROS1+ cancer is, and why it matters.

More on ROS1+ Cancer

Find the above video and more on TheROS1ders.org where you can learn more on making treatment decisions, handling disease progression and treatment resistance, and how to work with your care team to achieve better outcomes.

Treatment Options

ROS1der Janet Freeman-Daily (diagnosed in 2011) has a conversation with ROS1 expert Dr. Ross Camidge about targeted therapies and other options for treating ROS1+ cancer.

Treatment Resistance

ROS1der Amie Parker (diagnosed in 2017) discusses her experiences with disease progression, and ROS1 expert Dr. Tejas Patil shares his advice to patients confronting treatment resistance.

Self Advocacy

ROS1der Lysa Buonanno (diagnosed in 2011) shares her experiences with making decisions about care. ROS1 expert Dr. Tejas Patil weighs in on how patients, caregivers and doctors can work together most effectively.

We would like to thank The ROS1ders for its partnership.

This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make treatment decisions.